Gill, P S <br/><br/>
Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Aug 1996 
 - 2353-64 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.1996.14.8.2353  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acquired Immunodeficiency Syndrome--complications<br/>Adult<br/>Alopecia--chemically induced<br/>Antibiotics, Antineoplastic--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Bleomycin--administration & dosage<br/>Canada<br/>Daunorubicin--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Drug Carriers<br/>Female<br/>Humans<br/>Liposomes<br/>Male<br/>Middle Aged<br/>Neutropenia--chemically induced<br/>Prospective Studies<br/>Remission Induction<br/>Sarcoma, Kaposi--drug therapy<br/>Survival Rate<br/>Treatment Failure<br/>United States<br/>Vincristine--administration & dosage